Here, we tested the dual FAAH/MAGL inhibitor JZL195 in an animal model specific for migraine as a pharmacological probe to evaluate the impact of simultaneous inhibition of AEA and 2-AG degradation on the trigeminal system. The gene discussed is FAAH; the disease is migraine disorder.